Dhaarini Murugan

Tamil Nadu Dr. M.G.R. Medical University — India

Medicine · Health Sciences

9h-index2.5kcitations59works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(29), Immune Cell Function and Interaction(10), Immune cells in cancer(9), Immunodeficiency and Autoimmune Disorders(8), CAR-T cell therapy research(7)

Publications59 total

A Regulated Cytokine Engineering Strategy to Augment <i>in Vitro</i> and <i>In Vivo</i> persistence of Allogeneic iPSC Derived CD8 T-Cells
Blood·2024
SERUM MMP 9 AND hsCRP – MOLECULAR GUIDE FOR GRAFTING IN DIABETIC FOOT ULCER
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH·2024
An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequences
BMC Genomics·2023· 1 citedOpen Access
Supplemental Figure Legends from Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV&lt;sup&gt;+&lt;/sup&gt; Cancers
2023Open Access
Data from Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV&lt;sup&gt;+&lt;/sup&gt; Cancers
2023Open Access
Supplementary Figures from Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV&lt;sup&gt;+&lt;/sup&gt; Cancers
2023Open Access
Data from Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV&lt;sup&gt;+&lt;/sup&gt; Cancers
2023Open Access
Supplemental Figure Legends from Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV&lt;sup&gt;+&lt;/sup&gt; Cancers
2023Open Access
Supplementary Figures from Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV&lt;sup&gt;+&lt;/sup&gt; Cancers
2023Open Access
Abstract 4164: Relieving immune suppressive pathways in breast cancer to improve outcomes
Cancer Research·2023
Supplementary Table from T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62
2023Open Access
Supplementary Figure from T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62
2023Open Access
Supplementary Table from T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62
2023Open Access
Supplementary Table from T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62
2023Open Access
Supplementary Figure from T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62
2023Open Access
Supplementary Figure from T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62
2023Open Access
Supplementary Table from T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62
2023Open Access
Supplementary Figure from T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62
2023Open Access
Supplementary Figure from T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62
2023Open Access
Supplementary Figure from T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Lisa M. Coussens(41), Colin J. Daniel(26), Carl Pelz(26), Michael W. Munks(26), Aaron Ko(26), Sarah A. Byers(26), Eleonora Juarez(26), Karyn L. Taylor(26), Guang Fan(26), Jason M. Link(26), Rosalie C. Sears(26), Xiaoyan Wang(20), Daniel Kotlarz(8), Wesley Horton(7), Jana Diestelhorst(6), Sibylle Koletzko(6), Christoph Klein(6), Gabriele Galliverti(6), Stephan Wullschleger(6), Mélanie Tichet(6)